Agentschap voor Innovatie door Wetenschap en Technologie
Organisation
Trials
Collaborator, Early phase 1, Completed, 32 people, 23 Aug 2010
Collaborator, Early phase 1, Completed, 32 people, 13 Aug 2010
Collaborator, Phase 4, Completed, 400 people, 30 Jul 2010
Collaborator, Phase 3, Completed, 22 people, 31 Oct 2008
Collaborator, Phase 3, Completed, 276 people, 7 Aug 2008
Awards made
Baekeland, Combining cardiac progenitor therapy and tissue engineering for the treatment of heart failure, HBC.2021.0811, 2022–2026, 1 Mar 2022
Baekeland, Combining cardiac progenitor therapy and tissue engineering for the treatment of heart failure, HBC.2021.0811, 2022–2026, 1 Mar 2022
IWT / VLAIO - TETRA fund, EarCovered at work, HBC.2021.0107, 2021–2023, 1 Oct 2021
Baekeland, Baekeland mandate: EEG-based biomarkers for cognitive decline in mild cognitive impairment, HBC.2020.2304, 2020–2027, 1 Aug 2020
IWT / VLAIO personal funding - innovation mandates, Point-of-Care solution for osteoporosis management, vlaio-c271d99f-b07d-4187-ab1a-7a8e72dbc9e5, 2017–2019, 1 Apr 2017
IWT / VLAIO personal funding - innovation mandates, Point-of-Care solution for osteoporosis management, vlaio-c271d99f-b07d-4187-ab1a-7a8e72dbc9e5, 2017–2019, 1 Apr 2017
Sources: openalex.org